Evidence map›Paper›PMID 24249035›Full record

ReviewLangenbeck's archives of surgery2014

Clinical review: surgical management of locally advanced and recurrent colorectal cancer.

D Courtney, F McDermott, A Heeney, D C Winter

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Langenbeck's archives of surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04646772 (Surgery for Locally Advanced Colon Cancer), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04646772 unknown statusnot on this mapstarted 2021, after this paper: background citation

Surgery for Locally Advanced Colon Cancer: is it Worth it? A Multicenter Retrospective Analysis. (LACC Trial)

TypeobservationalSponsorSanto Spirito Hospital, ItalyRan2021 to 2021Enrolled100ConditionsMalignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4ArmsMultivisceral resection
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  10. Article
  11. The Impact of a Multivisceral Resection and Adjuvant Therapy in Locally Advanced Colon Cancer.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2019
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

D CourtneyDepartment of Surgery, St Vincent's University Hospital, Elm Park, Dublin 4, Republic of Ireland, nichurnd@tcd.ie.
F McDermott
A Heeney
D C Winter

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimRecurrent and locally advanced colorectal cancers frequently require en bloc resection of involved organs to achieve negative margins. The aim of this review is to evaluate the most current literature related to the surgical management of locally advanced and recurrent colorectal cancer.

methodsA literature review was performed on the electronic databases MEDLINE from PubMed, EMBASE and the Cochrane library for publications in the English language from January 1993 to July 2013. The MeSH search terms 'locally advanced colorectal cancer', 'recurrent colorectal cancer' and 'surgical management' were used.

resultsA total of 1,470 patients with recurrent or locally advanced primary colorectal cancer were included in 22 studies. Surgical removal of the tumour with negative margins (R0) offers the best prognosis in term of survival with a 5-year survival of up to 70 %. MVR is needed in approximately 10 % with the most commonly involved organ being the bladder. The mean post-operative morbidity is 40 %, mainly relating to superficial surgical site infection, pelvic collections and delayed wound healing. Most patients will undergo radiotherapy and/or chemotherapy pre- or post-operatively. The mean 5-year overall survival for R0 resection is 50 % for recurrent and locally advanced primary tumours while survival following R1 or R2 is 12 and <5 %, respectively.

conclusionMultimodal therapy and extended surgery to achieve clear margins offers good prognosis to patients with recurrent and locally advanced colorectal cancers.

Indexed as

Colorectal NeoplasmsDisease-Free SurvivalHumansIliac ArteryIliac VeinNeoplasm InvasivenessNeoplasm Recurrence, LocalNeoplasm StagingPelvic ExenterationPeritoneal LavagePostoperative ComplicationsSacrumUrogenital System

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.